OR WAIT null SECS
© 2022 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2022 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Early investment in formulation strategies will maximize the chance of success.
Advances in simulation and the development of digital twins.
Different methods give different answers when calculating limits for impurities.
Automatic visual inspection machines and AI highlight inspection deficits.
Despite their promise, alternative drug delivery approaches are complex and must be justified.
Traditional statistical process control rules can be relaxed or adjusted to allow charting and evaluation of real-life data.
Novavax COVID-19 Vaccine Receives EUA in Indonesia
January 25, 2022
UCB and Zogenix have agreed to an acquisition deal totaling nearly $2 billion.
Merck and Ridgeback Therapeutics will supply UNICEF with up to three million capsules of molnupiravir through the first half of 2022.
January 21, 2022
A report by international regulators reviews the effectiveness of current COVID-19 vaccines against the omicron variant.
The company is voluntarily recalling one batch of Semglee prefilled pens because of a potential missing label.
AstraZeneca's Tagrisso has been accepted for use as a monotherapy for the first-line treatment of adult patients with locally advanced or metastatic NSCLC with activating EGFR mutations in Scotland.
Air France KLM Martinair Cargo and Envirotainer are collaborating on more sustainable air transport of pharmaceuticals
PharmaLex Group has merged with MAP Group, broadening its market access expertise and extending its reach into the Italian marketplace.
Cyxone has appointed a European CDMO to scale-up and produce the active ingredient of its T20K drug candidate.
Colorcon Ventures is investing in a provider of intelligent manufacturing execution systems (MES), Apprentice.io.
January 20, 2022
Although there are challenges to be addressed, the digital transformation of equipment has begun.